Who
Laura Stoppel
Director
Company insider
Files Form 4 as: Director, Artiva Biotherapeutics; Director, Acumen Pharmaceuticals.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 30 Jun 2021
- Last trade
- 10 Sep 2026
- Last filed
- 14 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Sep 2026filed 14 Sep 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,250 at $0.00 | filing |
| 10 Sep 2026filed 14 Sep 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,250 at $0.00 | filing |
| 8 Sep 2026filed 8 Sep 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,750 at $0.00 | filing |
| 8 Sep 2026filed 8 Sep 2026 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,750 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ABOS Acumen PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —35,500 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —53,250 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —53,250 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | ABOS Acumen PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —35,500 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | ARTV Artiva Biotherapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,750 at $0.00 | filing |
| 4 Jun 2025filed 5 Jun 2025 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,500 at $0.00 | filing |
| 4 Jun 2025filed 5 Jun 2025 | ABOS Acumen PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —12,800 at $0.00 | filing |
| 10 Jun 2024filed 10 Jun 2024 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 6 Jun 2023filed 7 Jun 2023 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 30 Jun 2021filed 2 Jul 2021 | ABOS Acumen Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.